Directed evolution unlocks oxygen reactivity for a nicotine-degrading flavoenzyme

The flavoenzyme nicotine oxidoreductase (NicA2) is a promising injectable treatment to aid in the cessation of smoking, a behavior responsible for one in ten deaths worldwide. NicA2 acts by degrading nicotine in the bloodstream before it reaches the brain. Clinical use of NicA2 is limited by its poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulchavsky, Mark, Mitra, Rishav, Wu, Kevin, Li, Joshua, Boer, Karli, Liu, Xiaomeng, Zhang, Zhiyao, Vasquez, Cristian, Clark, Christopher T., Funckes, Kaitrin, Shankar, Kokila, Bonnet-Zahedi, Selene, Siddiq, Mohammad, Sepulveda, Yadira, Suhandynata, Raymond T., Momper, Jeremiah D., Calabrese, Antonio N., George, Olivier, Stull, Frederick, Bardwell, James C. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611581/
https://www.ncbi.nlm.nih.gov/pubmed/37770699
http://dx.doi.org/10.1038/s41589-023-01426-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611581/
https://www.ncbi.nlm.nih.gov/pubmed/37770699
http://dx.doi.org/10.1038/s41589-023-01426-y

Ejemplares similares